Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ReGen Theranostics

ReGen Theranostics
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Debt LATEST DEAL TYPE
$165K LATEST DEAL AMOUNT
1 INVESTORS
Description

Operator of a biotechnology company designed to provide stem cells. The company's stem cells are used by the researchers to produce patient-specific iPS cell lines for the research community on a fee-for-service basis, enabling researchers to recruit patients to biopsy and convert it into cryopreserved iPSC's.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 3033 41st Street North West
  • Suite 200
  • Rochester, MN 55901
  • United States

+1 (507) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ReGen Theranostics’s full profile, request a free trial.

ReGen Theranostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - General 01-Sep-2015 $165K 00000 Completed Generating Revenue
2. Early Stage VC 0000 Completed Generating Revenue
1. Debt - General 01-Aug-2010 $50K $50K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

ReGen Theranostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Mayo Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0

ReGen Theranostics Executive Team (1)

Name Title Board
Seat
Contact
Info
Matt Nelson President & Founder